We carried out a series of telephone interviews with
representatives from the 14 Area Drug and Therapeutics Committees
(ADTCs) across Scotland, in order to explore the perspectives of
healthcare professionals on how well members of the public are
involved in the work of the ADTCs.
This report, Approaches to
public involvement in NHS Board Area Drug and Therapeutics
Committees in NHSScotland, was commissioned by the ADTC Collaborative and
shares some of the learning on public involvement.
A total of 12 ADTCs involve members of the public, either on
their main committee or on sub-committees. Approaches varied but
most described it as a good experience with positive impact.
Including at least one public partner helps to maintain a focus on
the needs of patients, improves communication and helps to educate
communities on issues related to medicines.
Some of the more challenging aspects include recruitment and
training, dealing with technical discussions and confidential
matters and the impact of individuals' health on their ability to
participate. Support provided by ADTCs included induction
programmes, sending papers in advance of meetings and providing a
named contact for additional support.